Lee Financial’s F-star Therapeutics, Inc. Common Stock FSTX Stock Holding History

Lee Financial’s Portfolio FSTX Stock Details FSTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,688	Closed	-$25K	–	566
2020 Q3	$25K	Hold	4,688	–	–	0.01%	294
2020 Q2	$28K	Hold	4,688	–	–	0.01%	252
2020 Q1	$17K	Hold	4,688	–	–	0.01%	242
2019 Q4	$30K	Hold	4,688	–	–	0.01%	226
2019 Q3	$66K	Hold	4,688	–	–	0.01%	171
2019 Q2	$69K	Hold	4,688	–	–	0.02%	182
2019 Q1	$197K	Hold	4,688	–	–	0.05%	127
2018 Q4	$195K	Hold	4,688	–	–	0.05%	117
2018 Q3	$226K	Hold	4,688	–	–	0.06%	122
2018 Q2	$222K	Hold	4,688	–	–	0.05%	150
2018 Q1	$288K	Hold	4,688	–	–	0.07%	132
2017 Q4	$252K	Hold	4,688	–	–	0.07%	110
2017 Q3	$316K	Hold	4,688	–	–	0.1%	92
2017 Q2	$254K	Hold	4,688	–	–	0.09%	103
2017 Q1	$167K	Buy	+4,688	New	+$161K	0.07%	114

Other funds holding FSTX

AVA

Atlas Venture Advisors Boston, Massachusetts $122M AUM 26.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

STC

Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.19B AUM 20.87% 1-Year Est. Return

ECM

Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lee Financial's FSTX Position: Q4 2020 in Review

Lee Financial sold out of F-star Therapeutics, Inc. Common Stock (FSTX) in Q4 2020, closing a stake of 4,688 shares — an estimated $25K sold.

Lee Financial first reported a position in FSTX in Q1 2017 and held it in 15 quarters. The position peaked at $316K in Q3 2017. 21 funds tracked by Wall St. Rank hold FSTX as of Q4 2020.

Lee Financial reported no remaining F-star Therapeutics, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Lee Financial sold 4,688 F-star Therapeutics, Inc. Common Stock shares in Q4 2020, an estimated $25K.
Lee Financial first reported a position in F-star Therapeutics, Inc. Common Stock in Q1 2017 and held it in 15 quarters.
Lee Financial's F-star Therapeutics, Inc. Common Stock position peaked at $316K in Q3 2017.
21 funds tracked by Wall St. Rank held F-star Therapeutics, Inc. Common Stock as of Q4 2020.

Based on Lee Financial's 13F filing for Q4 2020, filed 12 Feb 2021.